
|Articles|December 1, 1996
Supplements and Featured Publications
- Pharmacoeconomic and Healthcare Outcomes Research: Managing and Treating Hypertension and Cardiovas
- Volume 2
- Issue 12 Suppl
An Analysis of Costs and Complications of Monophasic and Biphasic Implantable Cardioverter Defibrillators
Advertisement
Articles in this issue
over 29 years ago
Introductionover 29 years ago
Gatekeepers and Managed Care: Too Much of a Good Thing?over 29 years ago
MANAGED CARE CLINICAL CORNER: Chest Painover 29 years ago
Selected AbstractsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5




